Literature DB >> 9692743

Spatial discrimination learning and CA1 hippocampal synaptic plasticity in mdx and mdx3cv mice lacking dystrophin gene products.

C Vaillend1, J M Billard, T Claudepierre, A Rendon, P Dutar, A Ungerer.   

Abstract

Duchenne muscular dystrophy is frequently associated with a non-progressive cognitive deficit attributed to the absence of 427,000 mol. wt brain dystrophin, or to altered expression of other C-terminal products of this protein, Dp71 and/or Dp140. To further explore the role of these membrane cytoskeleton-associated proteins in brain function, we studied spatial learning and ex vivo synaptic plasticity in the mdx mouse, which lacks 427,000 mol. wt dystrophin, and in the mdx3cv mutant, which shows a dramatically reduced expression of all the dystrophin gene products known so far. We show that reference and working memories are largely unimpaired in the two mutant mice performing a spatial discrimination task in a radial maze. However, mdx3cv mice showed enhanced emotional reactivity and developed different strategies in learning the task, as compared to control mice. We also showed that both mutants display apparently normal levels of long-term potentiation and paired-pulse facilitation in the CA1 field of the hippocampus. On the other hand, an increased post-tetanic potentiation was shown by mdx, but not mdx3cv mice, which might be linked to calcium-regulatory defects. Otherwise, immunoblot analyses suggested an increased expression of a 400,000 mol. wt protein in brain extracts from both mdx and mdx3cv mice, but not in those from control mice. This protein might correspond to the dystrophin-homologue utrophin. The present results suggest that altered expression of dystrophin or C-terminal dystrophin proteins in brain did not markedly affect hippocampus-dependent spatial learning and CA1 hippocampal long-term potentiation in mdx and mdx3cv mice. The role of these membrane cytoskeleton-associated proteins in normal brain function and pathology remains to be elucidated. Furthermore, the possibility that redundant mechanisms could partially compensate for dystrophins' deficiency in the mdx and mdx3cv models should be further considered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692743     DOI: 10.1016/s0306-4522(98)00023-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

1.  Dysregulation of Intracellular Ca2+ in Dystrophic Cortical and Hippocampal Neurons.

Authors:  José R Lopez; Juan Kolster; Arkady Uryash; Eric Estève; Francisco Altamirano; José A Adams
Journal:  Mol Neurobiol       Date:  2016-12-15       Impact factor: 5.590

Review 2.  Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules.

Authors:  Mark G Rae; Dervla O'Malley
Journal:  J Neurophysiol       Date:  2016-07-06       Impact factor: 2.714

3.  Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy.

Authors:  Bo Deng; David Glanzman; James G Tidball
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

Review 4.  Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.

Authors:  Caroline Perronnet; Cyrille Vaillend
Journal:  J Biomed Biotechnol       Date:  2010-06-17

5.  Enhancing Endogenous Nitric Oxide by Whole Body Periodic Acceleration Elicits Neuroprotective Effects in Dystrophic Neurons.

Authors:  Jose R Lopez; A Uryash; J Kolster; E Estève; R Zhang; J A Adams
Journal:  Mol Neurobiol       Date:  2018-03-26       Impact factor: 5.590

6.  The shortest isoform of dystrophin (Dp40) interacts with a group of presynaptic proteins to form a presumptive novel complex in the mouse brain.

Authors:  Takenori Tozawa; Kyoko Itoh; Takeshi Yaoi; So Tando; Masafumi Umekage; Hongmei Dai; Hajime Hosoi; Shinji Fushiki
Journal:  Mol Neurobiol       Date:  2012-01-19       Impact factor: 5.590

Review 7.  Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy.

Authors:  Joe W McGreevy; Chady H Hakim; Mark A McIntosh; Dongsheng Duan
Journal:  Dis Model Mech       Date:  2015-03       Impact factor: 5.758

8.  Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Azeez Aranmolate; Nathaniel Tse; Holly Colognato
Journal:  BMC Neurosci       Date:  2017-08-14       Impact factor: 3.288

9.  Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions.

Authors:  Fatma Daoud; Aurora Candelario-Martínez; Jean-Marie Billard; Avi Avital; Malik Khelfaoui; Yael Rozenvald; Maryvonne Guegan; Dominique Mornet; Danielle Jaillard; Uri Nudel; Jamel Chelly; Dalila Martínez-Rojas; Serge Laroche; David Yaffe; Cyrille Vaillend
Journal:  PLoS One       Date:  2008-08-10       Impact factor: 3.240

10.  Characterization of a Dmd (EGFP) reporter mouse as a tool to investigate dystrophin expression.

Authors:  Mina V Petkova; Susanne Morales-Gonzales; Karima Relizani; Esther Gill; Franziska Seifert; Josefine Radke; Werner Stenzel; Luis Garcia; Helge Amthor; Markus Schuelke
Journal:  Skelet Muscle       Date:  2016-07-05       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.